We are live on ! Find out more
IC

Intel Corp Portfolio holdings

AUM $470M
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
-26.94%
1 Year Est. Return
-21.74%
3 Year Est. Return
+55.6%
5 Year Est. Return
-21.47%
10 Year Est. Return
AUM
$249M
AUM Growth
-$103M
Cap. Flow
+$3.01M
Cap. Flow %
1.21%
Top 10 Hldgs %
100%
Holding
5
New
2
Increased
Reduced
1
Closed

Top Buys

Rank Stock Value
1
SNTI icon
Senti Biosciences Holdings
SNTI
+$4.78M
2
ADT icon
ADT
ADT
+$1.02M

Top Sells

Rank Stock Value
1
KLTR icon
Kaltura
KLTR
+$2.8M

Sector Composition

Rank Sector Weight
1 Industrials 90.99%
2 Technology 8.54%
3 Healthcare 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JOBY icon
1
Joby Aviation
JOBY
$8.55B
$226M 90.63%
46,040,786
LIDR icon
2
AEye
LIDR
$61.1M
$13.2M 5.29%
230,398
KLTR icon
3
Kaltura
KLTR
$267M
$8.1M 3.25%
4,071,165
-1,634,370
-29% -$2.8M
SNTI icon
4
Senti Biosciences Holdings
SNTI
$11M
$1.17M 0.47%
+59,567
New +$4.78M
ADT icon
5
ADT
ADT
$5.58B
$904K 0.36%
+146,995
New +$1.02M

Similar funds

Intel Corp's Q2 2022 Portfolio in Review

As of Q2 2022, Intel Corp held 5 positions worth $249M, down 29% from $353M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Intel Corp's Q2 2022 filing shows 2 new and 1 reduced positions. Its largest new stake was Senti Biosciences Holdings: 59,567 shares worth $1.17M. The largest sale was Kaltura, an estimated $2.8M.

By sector, the portfolio is most concentrated in Industrials at 91% of assets, up from 86% a quarter earlier, followed by Technology and Healthcare.

  • Intel Corp's largest Q2 2022 buy was Senti Biosciences Holdings: 59,567 shares worth $1.17M.
  • Intel Corp's biggest Q2 2022 reduction was Kaltura, cutting an estimated $2.8M.
  • Intel Corp's ten largest holdings make up 100% of its $249M portfolio in Q2 2022.
  • Intel Corp opened 2 new positions and closed 0 in Q2 2022.
  • Intel Corp's portfolio value fell 29% quarter-over-quarter to $249M.

Based on Intel Corp's 13F filing for Q2 2022, filed 15 Aug 2022.